WSC
CELG

Wellington Shields & Co’s Celgene Corp CELG Stock Holding History

Wellington Shields & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,140
Closed -$660K – 227
2019
Q2 		$660K Hold
7,140
– – 0.31% 85
2019
Q1 		$674K Hold
7,140
– – 0.34% 80
2018
Q4 		$458K Buy
+7,140
New +$527K 0.26% 94

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Shields & Co's CELG Position: Q3 2019 in Review

Wellington Shields & Co sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 7,140 shares — an estimated $660K sold.

Wellington Shields & Co first reported a position in CELG in Q4 2018 and held it in 3 quarters. The position peaked at $674K in Q1 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Wellington Shields & Co reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Wellington Shields & Co sold 7,140 Celgene Corp shares in Q3 2019, an estimated $660K.
  • Wellington Shields & Co first reported a position in Celgene Corp in Q4 2018 and held it in 3 quarters.
  • Wellington Shields & Co's Celgene Corp position peaked at $674K in Q1 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Wellington Shields & Co's 13F filing for Q3 2019, filed 5 Nov 2019.